Sahajanand Medical Technologies IPO GMP, Allotment Date, Price & Listing Details

Sahajanand Medical Technologies IPO GMP Today

The Sahajanand Medical Technologies IPO GMP is an important indicator investors track to understand unofficial market sentiment before listing. Follow Finowings for the latest IPO GMP updates, allotment news, and listing details. However, GMP is unofficial and may fluctuate with market conditions. Investors should evaluate company fundamentals and risks before making investment decisions.

Sahajanand Medical Technologies IPO Details

The Sahajanand Medical Technologies IPO is a book-built issue worth ₹475.48 crore. The entire issue is an offer for sale of 1.38 crore shares. The IPO opened for subscription on October 15, 2026, and will close on October 19, 2026.

Sahajanand Medical Technologies IPO Price Band and Lot Size

The Sahajanand Medical Technologies IPO price band is ₹327 to ₹344 per share. The minimum application lot consists of 43 shares. Retail investors need ₹14,792 to apply for one lot at the upper price band. Check Finowings for IPO updates and important investment details before applying.

Sahajanand Medical Technologies IPO Allotment Date

The Sahajanand Medical Technologies IPO allotment is expected to be finalized on October 21, 2026. Investors should check the official registrar's website for allotment status after the results are announced. Keep your PAN, application number, or demat details ready to check your application status.

Sahajanand Medical Technologies IPO Listing Date

The Sahajanand Medical Technologies IPO is scheduled to list on the NSE and BSE on October 23, 2026. The actual listing price may differ from the issue price and unofficial GMP indications, depending on market demand and investor sentiment.

Sahajanand Medical Technologies IPO Investment Overview

Before applying, investors should review the IPO prospectus, financial performance, business risks, and official announcements. Follow Finowings for Sahajanand Medical Technologies IPO GMP, allotment updates, and listing information to stay informed throughout the IPO process.